HeartCore’s Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange
Company anticipates Q3 2024 revenue to be between $19 million-$23 million and net profit to be between $4 million-$8 million NEW YORK and TOKYO, Sept. 25, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR)… Read More »HeartCore’s Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange




